Delivery Order SPE2DB20D2104-SPE2DB24FV07D

Award Date 7/8/24
Potential Completion Date 7/29/24
Potential Value $4.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $7,030.77 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 10, 2024, with a completion date of January 2, 2025. The contract is a delivery order without any set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite...
This federal contract award is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML pharmaceutical products. The contract, valued at $4,687.18, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award, valued at $4,530.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of the pharmaceutical product TEZSPIRE 210 MG/1.91 ML PEN 1.91ML. The contract has an ultimate completion date of June 14, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to...
This contract awarded to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order worth $4,530.60 for the supply of the pharmaceutical product TEZSPIRE 210 MG/1.91 ML PEN 1.91ML. The contract was awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense, and has an ultimate completion date of July 31, 2024. Amerisourcebergen, one of the largest pharmaceutical distribution companies in the world, holds a $999,999,999.00 Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,343.59, is a Firm Fixed Price Delivery Order for the medical product "TEZSPIRE 210 MG/1.91 ML PEN 1.91ML". The contract has an ultimate completion date of January 30, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,530.60 Firm Fixed Price Delivery Order contract is for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a specialty pharmaceutical product. The contract has an ultimate completion date of November 24, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
The federal contract award summarized is for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Medical Supply Chain. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 18, 2024 with a ceiling value of $2,343.59. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 10, 2025. There was no set-aside designation for this...
The U.S. Defense Logistics Agency (DLA) awarded a $4,530.60 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a pharmaceutical product, with a period of performance through October 1, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of medical commodities, including prescription medications,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical product TEZSPIRE 210 MG/1.91 ML PEN 1.91ML. The $4,530.60 firm fixed-price delivery order was awarded on May 29, 2024 by the Defense Logistics Agency (DLA), with a completion date of June 20, 2024. This contract is not set aside for any specific business type. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract...
This federal contract award is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML pharmaceutical products to the Defense Logistics Agency (DLA). The $7,030.77 firm fixed price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 26, 2025, with a completion date of March 19, 2025. The contract is a delivery order under an Indefinite Delivery Contract valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB24FV07D
    Delivery Order

This federal contract award is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML pharmaceutical products to the U.S. Defense Logistics Agency (DLA). The $4,530.60 fixed-price delivery order was awarded to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 8, 2024. The contract has an ultimate completion date of July 29, 2024 and was not set aside for a specific business type.

Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for the company to supply a wide range of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as critical care materials, to DLA facilities supporting the Department of Defense worldwide.

Generated 10/7/24, 10:48 AM